CUV clinuvel pharmaceuticals limited

Indeed, CUV's plan, although we sometimes bemoan and complain,...

  1. 402 Posts.
    lightbulb Created with Sketch. 91
    Indeed, CUV's plan, although we sometimes bemoan and complain, does seem to be coming together very nicely in terms of revenue and profit. I REALLY want to buy more with the potential for the latest indications, but until I hear what the EMA say about the sixth indication, I'm actually afraid that, should it be negative, the historical shorting and manipulation could easily bring the SP to below $20 again. Having said that, with the historical safety data that CUV have produced upon which Scenesse has been approved as you say, I can't really see that they would spend time, effort and money on the sixth indication if they didn't believe that it would actually be efficacious to some degree.

    In anticipation of a fruitful meeting with the EMA..........

    GLA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$10.49
Change
-0.090(0.85%)
Mkt cap ! $525.7M
Open High Low Value Volume
$10.58 $10.68 $10.41 $803.9K 76.15K

Buyers (Bids)

No. Vol. Price($)
2 4258 $10.45
 

Sellers (Offers)

Price($) Vol. No.
$10.68 4000 3
View Market Depth
Last trade - 16.10pm 14/07/2025 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.